Abstract:Mixing a glutathione (GSH)-responsive carboxy zinc(II) phthalocyanine ( ZnPc* ) and CuSO 4 ·5H 2 O in water with or without the presence of the anticancer drug SN38 resulted in the formation of self-assembled nanotherapeutics labeled as ZnPc*/Cu/ and ZnPc*/ , respectively. The Cu 2+ ions not only promoted the self-assembly of the carboxy phthalocyanine through metal complexation, but also catalyzed the transformation of H 2 O 2 to oxygen via a catalase-like reaction, rendering an oxygen-replenishing property to the nanosystems. Both nanosystems exhibited high stability in aqueous media, but the nanoparticles disassembled gradually in an acidic or GSH-enriched environment and inside human colorectal adenocarcinoma HT29 cells, releasing the encapsulated therapeutic components. The disassembly process together with the activation by the intracellular GSH led to relaxation of the intrinsic quenching of the nanophotosensitizers and restoration of the photoactivities of ZnPc* . Under a hypoxic condition, ZnPc*/Cu/ could attenuate the intracellular hypoxia level and maintain the photodynamic activity due to its Cu 2+ -promoted oxygen-replenishing ability. The photodynamic effect of ZnPc* and the anticancer effect of SN38 worked cooperatively, causing substantial apoptotic cell death. The dual therapeutic actions could also effectively inhibit the tumor growth in HT29 tumor-bearing nude mice without initiating notable adverse effects to the mice. Statement of Significance The oxygen-dependent nature of photodynamic therapy generally reduces its efficacy against tumor hypoxia, which is a common characteristic of advanced solid tumors and usually leads to resistance toward various anticancer therapies. We report herein a facile approach to assemble a glutathione-responsive carboxy phthalocyanine-based photosensitizer and an anticancer drug in aqueous media, in which Cu(II) ions were used to promote the self-assembly through metal complexation and catalyze the conversion of H 2 O 2 to oxygen through a catalase-like reaction, making the resulting nanoparticles possessing an oxygen-replenishing property that could promote the photodynamic effect against hypoxic cancer cells and tumors. The use of Cu(II) ions to achieve the aforementioned dual functions in the fabrication of advanced nano-photosensitizing systems has not been reported.

Water Soluble Cu(II) and Ni(II) Phthalocyanine: Syntheses and in Vitro Synergistic Anticancer Activities of Photodynamic Therapy and Chemotherapy Effects

A novel water-soluble phthalocyanine-based organic molecule for the effective NIR triggered dual phototherapy of cancer

Dithiocarbazate–Zn(II) complexes for photodynamic therapy and chemotherapy against lung cancer

Synthesis and Spectral Properties of Water-Soluble Phthalocyanine-Based Photosensitizers

Cover Feature: Photoactivated Anticancer Activity of Cobalt(III) Complexes with Naturally Occurring Flavonoids Chrysin and Silibinin (ChemBioChem 20/2024)

Cu(II) flavonoids as potential photochemotherapeutic agents

Cupric-ion-promoted fabrication of oxygen-replenishing nanotherapeutics for synergistic chemo and photodynamic therapy against tumor hypoxia

BODIPY-based Monofunctional Pt (II) Complexes for Specific Photocytotoxicity Against Cancer Cells

Syntheses of Metal Phthalocyanines and Their Photoinactivations on Cancer Cells.

Photoactivatable Dihydroalkaloids for Cancer Cell Imaging and Chemotherapy with High Spatiotemporal Resolution

Synthesis and antitumor study of novel porphyrin–coumarin derivatives for chemotherapy and photodynamic therapy

Copper (II) Complexes Modified with Water-Soluble Porphyrin and Various Small Molecules Ligand for DNA Binding and Potential Selectivity Antitumor Agents

Applying Cu(II) complexes assisted by water‐soluble porphyrin to DNA binding and selective anticancer activities

Design, Synthesis, and biological evaluation of copper(II) complexes with phenanthroline-based ligands as potential anticancer agents

Design, Synthesis, and Anti-Cancer Evaluation of Novel Water-Soluble Copper(I) Complexes Bearing Terpyridine and PTA Ligands

A Pair of Deep Red Phosphorescent Responsive Emissive Cyclometalated Iridium (III) Complexes as Carbonic Anhydrase Inhibitor and Effective Theranostic Photosensitizer

Synthesis of three new copper(II) compounds for chemodynamic therapy against cancer cells

Copper(I) Complexes With Phenanthroline‐Functionalized NHC Ligands Achieve Effective Anticancer Activity via Mitochondrial and Endoplasmic Reticulum Stress

Post-synthesis strategy to integrate porphyrinic metal-organic frameworks with CuS NPs for synergistic enhanced photo-therapy

Two Water-Soluble Copper(ii) Complexes: Synthesis, Characterization, DNA Cleavage, Protein Binding Activities and in Vitro Anticancer Activity Studies.

Studies on the synthesis and photodynamic antitumour activity of sulfonated phthalimidomethyl phthalocyanine zinc